Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). (2020)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cti2.1182
PubMed Identifier: 33005417
Publication URI: http://europepmc.org/abstract/MED/33005417
Type: Journal Article/Review
Volume: 9
Parent Publication: Clinical & translational immunology
Issue: 9
ISSN: 2050-0068